ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Zydus Lifesciences Ltd Complete list of announcements declared & dividend announcements by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences Ltd ZYDUSLIFE listed on NSE and deals in

Announcements and dividends declared by Zydus Lifesciences Ltd ZYDUSLIFE

Zydus Lifesciences gets USFDA nod to produce prostate cancer treatment drug
Zydus Lifesciences Ltd has received final approval from the USFDA to manufacture 60 mg Apalutamide tablets for prostate cancer treatment. These tablets will be produced at their Ahmedabad facility. Apalutamide, an androgen receptor inhibitor, is intended f
Announcement as on 18 March 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 16, 2025, titled "Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg".
Announcement as on 17 March 2025

Company Announcement
Zydus Lifesciences Limited has informed the Exchange about Schedule of meet
Announcement as on 11 March 2025

Zydus Lifesciences to buy 86% stake in French medical devices maker
India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly 0 million to expand in the global medical devices market. The acquisition, at a premium of nearly 81% to Amplitude's last close, aims to leverage growt
Announcement as on 11 March 2025

Zydus Lifesciences gets USFDA nod to market generic antifungal shampoo
Zydus Lifesciences received approval from the USFDA to market Ketoconazole Shampoo, an antifungal medication, in the US. This approval is for a generic version targeting dandruff and various fungal infections. The medication will be produced at Zydus's man
Announcement as on 10 March 2025

Announcements by Zydus Lifesciences Ltd first page | Next page | Prev page |

ZYDUSLIFE Zydus Lifesciences Ltd current price & indicator signals

Moving Averages for Zydus Lifesciences Ltd

  • 5Day Average: 1074.68
  • 12Day Average: 1087.43
  • 20Day Average: 1082.48
  • 50Day Average: 999.48
  • 100Day Average: 948.6
  • 150Day Average: 938.92
  • 200Day Average: 954.52

ZYDUSLIFE Indicators & signals

Indicator MACD (12,26,9)

1078.47, 1056.27, 30.48
Indicator MACD is in positive zone

Indicator ADX (14)

17.97, 25.33, 17.61
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ZYDUSLIFE Zydus Lifesciences Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Fri Jun 2026 1070.80 1065.00 to 1083.00 -0.34% 0.79 times
18 Thu Jun 2026 1074.40 1060.60 to 1082.50 1.22% 1.17 times
17 Wed Jun 2026 1061.40 1053.80 to 1077.80 -1.6% 2.22 times
16 Tue Jun 2026 1078.70 1072.40 to 1091.60 -0.86% 0.93 times
15 Mon Jun 2026 1088.10 1086.00 to 1112.10 -1.5% 1.01 times
12 Fri Jun 2026 1104.70 1101.70 to 1118.00 -0.11% 0.78 times
11 Thu Jun 2026 1105.90 1091.20 to 1110.40 0.69% 0.65 times
10 Wed Jun 2026 1098.30 1095.10 to 1119.80 -0.66% 0.53 times
09 Tue Jun 2026 1105.60 1085.50 to 1111.00 1.66% 1.16 times
08 Mon Jun 2026 1087.60 1076.20 to 1100.00 -0.13% 0.74 times
05 Fri Jun 2026 1089.00 1082.20 to 1097.00 0.41% 0.82 times
04 Thu Jun 2026 1084.60 1063.10 to 1098.00 0.74% 0.9 times

Videos related to: ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ZYDUSLIFE announcements Zydus Lifesciences Ltd announcements and dividends declared NSE

 

Back to top